Table of Contents Table of Contents
Previous Page  944 / 1631 Next Page
Information
Show Menu
Previous Page 944 / 1631 Next Page
Page Background

DLBCL: PFS and OS significantly longer with Pola-BR

Progression Free Survival

% Patients

Months

Overall Survival

% Patients

Months

92